Ras proteins act as molecular switches, responding to signals by entering the active GTP-bound, rather than the inactive GDP-bound, state. The inhibition of normal Ras proteins by microinjection of neutralizing antibody or expression of dominant-negative mutants has shown that Ras signalling is required for growth factors to stimulate DNA synthesis [1,2], but the link between Ras and the cell-cycle machinery is not clear. Regulation of the phosphorylation state of the retinoblastoma protein (pRb), the product of the tumour suppressor gene Rb, is a key event in the progression of cells from G1 phase into S phase. In growth-arrested or early G1 cells, pRb is hypophosphorylated and binds to transcription factors of the E2F family [3]. These pRb-E2F complexes act to suppress gene transcription required for entry into DNA synthesis either by preventing E2F from stimulating transcription or by actively repressing transcription [4] . During G1, cyclin-dependent kinases (CDKs) become activated and phosphorylate pRb at multiple sites, leading to the dissolution of pRb-E2F complexes and gene transcription [5] . Here, we have tested the hypothesis that Ras signalling is required for the inactivation of pRb. A neutralizing antibody directed against p21Ras was microinjected into cells derived from mutant mouse embryos that lack Rb or CDK inhibitors (CDKIs). Cells without pRb or the p16 CDKI were more resistant to the inhibitory effects of the anti-Ras antibody. DNA synthesis in some tumour cell lines was completely resistant to the anti-Ras injection, indicating that p21Ras is required for pRb inactivation but also has other functions in cell-cycle progression. 
The Ras-neutralizing monoclonal antibody Y13-259 [6] has been shown in a variety of systems to block Rasdependent signalling, probably by preventing the formation of a complex between p21Ras-GTP and Ras effectors [1, 7] . To determine whether Ras signalling was required for the inactivation of Rb, we injected Y13-259 into mouse embryo fibroblasts (MEFs) derived from homozygous mouse embryos that lack Rb as a result of germline manipulation [8] . As a control for effects of the microinjection procedure, MEFs were injected with rat immunoglobulin. Asynchronous growing cultures were Table 1 Deletion of pRb reduces sensitivity to inhibition of DNA synthesis by microinjection of Ras-neutralizing antibody. [24] . Retrovirus stocks were produced by transfecting pBabe-puro-HsRb into BOSC 23, as described [25] . Subconfluent cultures of Rb -/-MEFs were then infected with pBabe-puro-HsRb retrovirus stock or pBabe-puro retrovirus stock and transduced cells selected by incubation in DMEM / 10% serum containing 6 g ml -1 puromycin. After 7-8 days, cultures were confluent and used for microinjection as described above. Expression of human Rb was detected by indirect immunofluorescence using the pRb-specific antibody 245 (Pharmingen To extend and confirm these effects, we examined whether the introduction of wild-type Rb into Rb -/-MEFs would restore sensitivity to Y13-259 injection. Rb -/-MEFs were infected with a retrovirus vector (pBabe-puro-HsRb) carrying the human Rb gene and the gene for puromycin resistance, or with the empty vector (pBabe-puro), and puromycin-resistant cells were selected. More than 95% of the puromycin-resistant cells infected with pBabe-puro-HsRb expressed human pRB (Fig. 1a,b) . Figure 1d and Table 1 show that introduction of wild-type Rb restores complete sensitivity to inhibition of DNA synthesis by injection of Y13-259 (inhibition 84-98%). The injection of Y13-259 into puromycin-resistant Rb -/-MEFs infected with the empty vector inhibited DNA synthesis by 46-50% (Fig. 1c and Table 1 ). The experiments presented in Table 1 therefore show that cells lacking pRb have a reduced requirement for p21Ras signalling, suggesting that the inactivation of pRb is one of the functions of p21Ras signalling that promotes cell proliferation.
Cells
The ability of pRb to suppress entry into DNA synthesis is overcome through its phosphorylation by G1 CDKs [9, 10] . The activity of these kinases has been shown to be regulated at the level of transcriptional activation of D-and E-type cyclins or by CDKIs [11, 12] . Two general classes of CDKIs have been identified: the p16 family, members of which bind directly to CDK4/CDK6 and specifically regulate cyclin-D-dependent kinases; and the p21 family, members of which bind to CDK-cyclin complexes and Asynchronously growing cells were injected with Y13-259 or rat IgG and processed as described in Table 1 .
regulate a much broader range of CDKs. To determine whether Ras signalling was affected by the loss of CDKIs, MEFs from p16 Ink4-/-and p21 Waf1-/-embryos were microinjected with Y13-259 and the effects on DNA synthesis measured. Table 2 shows that DNA synthesis in p16 Ink4-/-cells was as resistant to Y13-259 injection as Rb -/-cells, whereas p21 Waf1-/-cells were as sensitive to Y13-259 as cells with wild-type Rb. Furthermore, tumour-derived cell lines for which loss of pRb or p16 has been demonstrated (HaCat, SaOS2, C33a and J82) were resistant to Y13-259 injection to a degree similar to, or higher than, pRb -or p16 -deficient MEFs.
These experiments show that the inactivation of Rb requires normal Ras function. The experiments with p16 Ink4-/-cells show that a target of Ras-dependent signalling is the activation of cyclin-D-dependent kinases. Consistent with these data, previous work has shown that the introduction of adenovirus E1A protein stimulates DNA synthesis in cells injected with Y13-259 [13] . E1A complexes with and inactivates Rb, but also has other functions that include binding to the other 'pocket' proteins, p107 and p130, and to the transcriptional co-regulator p300 [14, 15] . Table 2 and [16] ), suggesting that these tumour cells have additional genetic alterations that liberate them from any requirement for Ras function. The residual sensitivity of MEF Rb -/-and MEF p16 -/-cells to Y13-259 injection could result from p21Ras having multiple functions in cellcycle progression. Taylor and Shalloway [17] have recently shown that, following the early G1 growth-factor-stimulated activation of Ras, there is a later mid-G1 phase of Ras activation which appears to be independent of extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP) kinase activation, consistent with Ras-dependent signalling being required at different times in G1 [18] . As we have injected asynchronously growing cells, Rb -/-or p16 -/-MEFs inhibited by Y13-259 may have been injected at time points when Ras-dependent function(s) other than pRb inactivation were required for progression to DNA synthesis.
A requirement for Ras activation at several points in the cell cycle is also consistent with Ras being required for stimulation of several signalling pathways that lead to DNA synthesis, including the ERK MAP kinase pathway and the phosphatidylinositol 3-kinase pathway [19] [20] [21] . Ras-dependent activation of the ERK MAP kinase pathway does seem to be required for proliferation of Rb -/-MEFs, as we have observed that DNA synthesis in Rb -/-MEFs is as sensitive to PD 098059, an inhibitor of the ERK activator MEK [22] , as are Rb +/-cells (S.M., unpublished data).
